Abrdn PLC Neogenomics Inc Transaction History
Abrdn PLC
- $50.5 Billion
- Q1 2025
A detailed history of Abrdn PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Abrdn PLC holds 413,098 shares of NEO stock, worth $3.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
413,098Holding current value
$3.07 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$146 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$106 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$49.8 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$44.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$42.6 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $933M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...